Publication | Closed Access

The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial

VaccinationVaccine SafetyVaccinologyPreventive MedicineImmunologyRandomised Double-blindVaccine TrialVaccine EfficacyPlacebo-controlled Phase 1/2Infection ControlMedicineVaccine Research